GeoVax Labs(us:GOVX)

    2.21

    -3.49%

    Updated on 2024-12-23

    Open:2.33
    Close:2.21
    High:2.33
    Low:2.13
    Pre Close:2.29
    Volume:673604.00
    Amount:1.47M
    Turnover:7.14%
    Shares:9.44M
    MarketCap:20.83M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30131943674.65%233
    2024-03-311624080610.43%1410
    2023-12-31172090870.70%315
    2023-09-30181038260.39%127
    2023-06-302016112346.09%225
    2023-03-312416072766.08%4310
    2022-12-312621329848.10%3611
    2022-09-3025311142611.81%7106
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Armistice Capital, Llc1780007.71%6956064.15%
    2024-03-31Blackrock Inc.275651.19%10.00%
    2024-03-31Vanguard Group Inc192390.83%-29326-60.38%
    2024-03-31Geode Capital Management, Llc111610.48%-366-3.17%
    2024-03-31Tower Research Capital Llc (Trc)44710.19%3787553.65%
    2024-03-31Wells Fargo & Company/Mn2170.01%-63-22.50%
    2024-03-31Morgan Stanley1200.01%-16-11.77%
    2024-03-31Global Retirement Partners, Llc270.00%0
    2024-03-31Royal Bank Of Canada40.00%133.33%
    2024-03-31Fmr Llc11

    About

    GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
    Address:1900 Lake Park Drive,Suite 380

    Market Movers